hypertension therapeutics - second half

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/50

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 9:41 PM on 9/14/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

51 Terms

1
New cards

name the loop diuretics

bumetanide, furosemide, torsemide

2
New cards

adverse effects of loop diuretics

-dehydration

-hypotension

-decreased Na, K, Mg, Cl

-increased glucose, uric acid, LDL-C, TG

3
New cards

contraindications of loop diuretics

-anuria

-caution with sulfa allergies (not ethacrynic acid)

4
New cards

loop diuretics monitoring

-BP

-electrolytes

-renal function

-fluid status

-glucose

-uric acid

5
New cards

loop diuretics drug interactions

NSAIDs

6
New cards

name the potassium sparing diuretics

-amiloride

-triamterene

-eplerenone

-spirnoloactone

7
New cards

adverse effects of potassium spring diuretics

-dehydration

-hyperkalemia

-hyponatremia

-dizziness

8
New cards

adverse effects of spironolactone

-gynecomastia

-breast tenderness

-irregular menses

9
New cards

contraindications of potassium sparing diuretics

-hyperkalemia

-anuria

-renal impairment

-concurrent use of potassium sparing diuretics of potassium supplementation

10
New cards

potassium sparing diuretics monitoring

-BP

-electrolytes

-renal function

-fluid status

11
New cards

potassium sparing diuretics drug interactions

strong CYP3A4 inhibitor

12
New cards

name the cardioselective beta 1 blockers

-atenolol

-betaxolol

-bisoprolol

-esmolol

-metoprolol tartrate

-metoprolol succinate

13
New cards

name the cardioselective and vasodilatory beta blockers

Nebivolol

14
New cards

name the non-cardioselective beta-1 and beta-2 blockers

-nadolol

-propranolol IR

-propranolol LA

15
New cards

name the intrinsic sympathomimetic activity beta blockers

-acebutolol

-carteolol

-penbutolol

-pindolol

16
New cards

name the non-cardioselective beta blocker and alpha-1 blocker

-carvedilol

-carvedilol phosphate

-labetalol

17
New cards

adverse effects of beta blockers

-bradycardia

-hypotension

-fatigue

-dizziness

-depression

-decreased libido

-mask symptoms of hypoglycemia

-rebound hypertension if abrupt discontinuation

18
New cards

contraindications of beta blockers

-severe bradycardia

-2nd or 3rd degree AV block

-cardiogenic shock

19
New cards

beta blockers monitoring

HR, BP, ECG

20
New cards

beta blockers drug interactions

other drugs that decrease heart rate

21
New cards

what are the direct renin inhibitors

aliskiren

22
New cards

adverse effects of direct renin inhibitors

-angioedema

-hyperkalemia

-hypotension

-renal dysfunction

-diarrhea

23
New cards

contraindications of direct renin inhibitors

-use with ACE or ARBs in patients with diabetes

-bilateral renal artery stenosis

-pregnancy

24
New cards

direct renin inhibitors monitoring

-BP

-potassium

-renal function

25
New cards

direct renin inhibitors drug interactions

RAAS inhibitors

26
New cards

name the alpha 1 blockers

-doxazosin

-prazosin

-terazosin

27
New cards

adverse effects of alpha 1 blockers

-orthostatic hypotension

-syncope

-fatigue

-dizziness

-headache

-edema

28
New cards

contraindications of alpha 1 blockers

hypersensitivity to drug

29
New cards

monitoring of alpha 1 blockers

BP

30
New cards

drug interactions of alpha 1 blockers

caution with other drugs that decrease BP, PDE-5 inhibitors

31
New cards

name the centrally acting alpha 2 agonists

-clonidine oral and patch

-guanfacine IR

-methyldopa

32
New cards

adverse effects of centrally acting alpha 2 agonists

-bradycardia

-hypotension

-dry mouth

-headache

-fatigue

-dizziness

-depression

-constipation

-rebound hypertension if abrupt discontinuation

-drug induced lupus

33
New cards

contraindication of centrally acting alpha 2 agonists

methyldopa - active liver disease, concurrent use either MAO inhibitors

34
New cards

centrally acting alpha 2 agonists monitoring

BP, HR, mental status

35
New cards

centrally acting alpha 2 agonists drug interactions

beta blockers

36
New cards

name the direct vasodilators

hydralazine, minoxidil

37
New cards

adverse effects of hydralazine

-headache

-hypotension

-reflex tachycardia

-palpitations

-drug induced lupus

38
New cards

adverse effects of minoxidil

-fluid retention

-tachycardia

-hair growth

39
New cards

contraindications of hydralazine

-mitral valve rheumatic heart disease

-coronary artery disease

40
New cards

contraindications of minoxidil

pheochromocytoma

41
New cards

direct vasodilators monitors

BP, HR, antinuclear antibody titer

42
New cards

direct vasodilators drug interactions

caution with other drugs that decrease BP

43
New cards

what three antihypertensive therapies are preferred in pregnancy

methyldopa, labetalol, nifedipine ER

44
New cards

what drugs are contraindicated in therapy

ACE-I, ARB, direct renin inhibitor

45
New cards

what is considered a hypertensive emergency

severe elevations in BP (>180/120) associated with evidence of new or worsening organ damage

46
New cards

how should BP be lowered in a hypertensive emergency

decrease BP by no more than 25% within the first hour, if stable decrease to 160/100 within the next two hours, then decrease to normal over next 24-48 hours

47
New cards

treatment of a hypertensive emergency

initiate IV hypertensive therapy

48
New cards

what IV hypertensive therapies can be initiated during a hypertensive emergency

esmolol, labetalol, hydralazine, nicardipine, nitroglycerin, nitroprusside

49
New cards

what is the definition of a hypertensive urgency

severe elevations in BP (> 180/120) without acute target organ damage

50
New cards

how should BP be lowered in a hypertensive urgency

decrease BP gradually over 24-48 hours

51
New cards

treatment of a hypertensive urgency

reinitiate or intensify oral antihypertensive drug therapy